Synthego is a biotechnology company focused on CRISPR and molecular diagnostics, delivering high-quality, scalable solutions for CRISPR research, molecular biology workflows, and diagnostic applications. The company positions itself as a partner in CRISPR and molecular diagnostics, supporting cell and gene therapy development with GMP-grade nucleases, RNA and DNA reagents, and engineered base editors. With a global reach and a portfolio spanning CRISPR gene editing, GMP manufacturing, and molecular diagnostics, Synthego emphasizes clinical and research applications aimed at accelerating human health. The company also highlights regulatory expertise and manufacturing capabilities to support IND submissions and clinical programs.
No recent deals for this company.